Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a

Journal of Endocrinology

Volumn 188, Issue 1, 2006, Pages 37-47

  Delhanty, P J D ^a   van der Eerden, B C J ^a   van der Velde, M ^a   Gauna, C ^a   Pols, H A P ^a   Jahr, H ^a   Chiba, H ^b   van der Lely, A J ^a   van Leeuwen, J P T M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1A; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RNA; THYMIDINE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BONE BIOPSY; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DNA; FEMUR HEAD; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; PEPTIDE HORMONES; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL; THYMIDINE;

EID: 31544452274     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06404     Document Type: Article

References (37)

1. Andreis PG, Malendowicz LK, Trejter M, Neri G, Spinazzi R, Rossi GP & Nussdorfer GG 2003 Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Letters 536 173-179.
2. Ariyasu H, Takaya K, Iwakura H, Hosoda H, Akamizu T, Arai Y, Kangawa K & Nakao K 2004 Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 146 355-364.
3. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F et al. 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. Journal of Cell Biology 159 1029-1037.
4. Bernstein CN, Leslie WD & Leboff MS 2003 AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124 795-841.
5. Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Granata R, Papotti M, Muccioli G, Deghenghi R & Ghigo E 2002 Ghrelin: much more than a natural growth hormone secretagogue. Israeli Medical Association Journal 4 607-613.
6. Bustin SA & Nolan T 2004 Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. Journal of Biomolecular Technology 15 155-166.
7. Chan CB & Cheng CH 2004 Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli. Molecular & Cellular Endocrinology 214 81-95.
8. Eijken M, Hewison M, Cooper MS, de Jong FH, Chiba H, Stewart PM, Uitterlinden AG, Pols HA & van Leeuwen JP 2005 11 beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Molecular Endocrinology 19 621-631.
9. Feighner SD, Howard AD, Prendergast K, Palyha OC, Hreniuk DL, Nargund R, Underwood D, Tata JR, Dean DC, Tan CP et al. 1998 Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Molecular Endocrinology 12 137-145.
10. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, Takeda S, Takeuchi Y, Fukumoto S, Kangawa K et al. 2005 Ghrelin directly regulates bone formation. Journal of Bone Mineral Research 20 790-798.
11. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB & Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology & Metabolism 87 2988.
12. Grey A, Chen Q, Callon K, Xu X, Reid IR & Cornish J 2002 The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. Endocrinology 143 4755-4763.
13. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH & Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Molecular Brain Research 48 23-29.
14. Holst B, Cygankiewicz A, Halkjar Jensen T, Ankersen M & Schwartz TW 2003 High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Molecular Endocrinology 17 2201-2210.
15. Howard AD, Feighner SD, Cully DE, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 974-977.
16. Jansen JH, Weyts FA, Westbroek I, Jahr H, Chiba H, Pols HA, Verhaar JA, van Leeuwen JP & Weinans H 2004 Stretch-induced phosphorylation of ERK1/ 2 depends on differentiation stage of osteoblasts. Journal of Cell Biochemistry 93 542-551.
17. Jeffery PL, Herington AC & Chopin LK 2003 The potential autocrine/ paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cyrokine Growth Factor Reviews 14 113-122.
18. Kim MS, Yoon CY, Jang PG, Park YJ, Shin CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU et al. 2004 The mitogenic and anti-apoptotic actions of ghrelin in 3T3-L1 adipocytes. Molecular Endocrinology 18 2291-2301.
19. Kim SW, Her SJ, Park SJ, Kim D, Park KS, Lee HK, Han BH, Kim MS, Shin CS & Kim SY 2005 Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 Cells. Bone 37 359-369.
20. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 656-660.
21. Kojima M & Kangawa K 2005 Ghrelin: structure and function. Physiological Reviews 85 495-522.
22. Larsson B, Gritli-Linde A, Norlen P, Lindstrom E, Hakanson R & Linde A 2001 Extracts of ECL-cell granules/vesicles and of isolated ECL cells from rat oxyntic mucosa evoke a Ca2+ second messenger response in osteoblastic cells. Regulatory Peptides 97 153-161.
23. Larsson B, Norlen P, Lindstrom E, Zhao D, Hakanson R & Linde A 2002 Effects of ECL cell extracts and granule/vesicle-enriched fractions from rat oxyntic mucosa on cAMP and IP(3) in rat osteoblast-like cells. Regulatory Peptides 106 13-18.
24. Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C & Cocchi D 2005 Ghrelin regulates proliferation and differentiation of osteoblastic cells. Journal of Endocrinology 184 249-256.
25. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K & Chihara K 2002 Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. Journal of Biological Chemistry 277 5667-5674.
26. Nanzer AM, Khalaf S, Mozid AM, Fowkes RC, Patel MV, Burrin JM, Grossman AB & Korbonits M 2004 Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. European Journal of Endocrinology 151 233-240.
27. Osyczka AM & Leboy PS 2005 Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling, Endocrinology 146 3428-3437.
28. Papotti M, Ghe C, Cassoni P, Catapano F, Deghenghi R, Ghigo E & Muccioli G 2000 Growth hormone secretagogue binding sites in peripheral human tissues. Journal of Clinical Endocrinology & Metabolism 85 3803-3807.
29. Sibilia V, Cocchi D, Pagani F, Lattuada N, Moro GL, Pecile A, Rubinacci A, Muller EE & Netti C 1999 Hexarelin, a growth hormone - releasing peptide, counteracts bone loss in gonadectomized male rats. Growth Hormone IGF Research 9 219-227.
30. Sun Y, Ahmed S & Smith RG 2003 Deletion of ghrelin impairs neither growth nor appetite. Molecular and Cellular Biology 23 7973-7981.
31. Sun Y, Wang P, Zheng H & Smith RG 2004 Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor, PNAS 101 4679-4684.
32. Tamura H, Kamegai J, Sugihara H, Kineman RD, Frohman LA & Wakabayashi I 2000 Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. Journal of Neuroendocrinology 12 481-485.
33. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC & Wells T 2003 Ghrelin and des-octanoyl ghrelin promote adipogenesis directlyin vivo by a mechanism independent of GHS-R1a. Endocrinology 145 234-242.
34. van der Lely AJ, Tschop M, Heiman ML & Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 25 426-457.
35. Weyts FA, Bosmans B, Niesing R, Leeuwen JP & Weinans H 2003 Mechanical control of human osteoblast apoptosis and proliferation in relation to differentiation. Calcified Tissue International 72 505-512.
36. Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD et al. 2004 Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. PNAS 101 8227-8232.
37. Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I & Mulholland MW 2004 Inhibition of adipogenesis by ghrelin. Molecular Biology of Cell 15 2484-2491.